Current clinical practice including treatment patterns and pathways in idiopathic pulmonary fibrosis patients in China: A real-world analysis
Pharmacoeconomics and Policy · 2026-03 · 2 (1) · 27-37
DOI: 10.1016/j.pharp.2026.03.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoeconomics and Policy, 2026-03. Verfasst von Han Bao und 6 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Boehringer Ingelheim
Zitieren
APA
Bao, H., Jian, Y., Penaloza-Ramos, C., Kanakapura, M., Deng, Z., Xuan, J., & Zhao, H. (2026). Current clinical practice including treatment patterns and pathways in idiopathic pulmonary fibrosis patients in China: A real-world analysis. Pharmacoeconomics and Policy, 2(1), 27-37. https://doi.org/10.1016/j.pharp.2026.03.005
Vancouver
Bao H, Jian Y, Penaloza-Ramos C, Kanakapura M, Deng Z, Xuan J, et al. Current clinical practice including treatment patterns and pathways in idiopathic pulmonary fibrosis patients in China: A real-world analysis. Pharmacoeconomics and Policy. 2026;2(1):27-37. doi:10.1016/j.pharp.2026.03.005
BibTeX
@article{Bao2026,
author = {Bao, Han and Jian, Yifei and Penaloza-Ramos, Cristina and Kanakapura, Madhu and Deng, Zhongyi and Xuan, Jianwei and Zhao, Hui},
title = {Current clinical practice including treatment patterns and pathways in idiopathic pulmonary fibrosis patients in China: A real-world analysis},
journal = {Pharmacoeconomics and Policy},
year = {2026},
volume = {2},
number = {1},
pages = {27--37},
doi = {10.1016/j.pharp.2026.03.005}
}
EUVIMED